Amprion, Inc. – Trademark Portfolio
Entity Type: 03
Amprion, Inc. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 22 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 11 trademarks are registered and 6 are pending. Notable registered marks include ALLTAP, ALZTAP, LBDTAP, PROTAP, and SYNTAP. The owner is based in San Francisco, CA.
149 New Montgomery Street
4th Floor
San Francisco, CA 94105
Showing of trademarks Trademarks
Trademark Classifications
Amprion, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Amprion, Inc. have?
Amprion, Inc. has 25 U.S. trademarks filed with the USPTO. Of these, 11 registered, 6 pending, 8 abandoned.
What trademark classes does Amprion, Inc. file in?
Amprion, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Amprion, Inc.'s most well-known trademarks?
Amprion, Inc.'s registered trademark portfolio includes well-known marks such as ALLTAP, ALZTAP, LBDTAP, PROTAP, and SYNTAP. These are among 11 currently registered trademarks in the portfolio.
What is Amprion, Inc.'s trademark registration success rate?
Amprion, Inc. has a 58% trademark registration rate, with 11 out of 19 resolved applications resulting in successful registration. Currently, 6 applications are pending review.